Alpha Tau Medical Ltd (DRTS) has released an update.
Alpha Tau Medical Ltd., an Israeli oncology therapeutics company, will be showcasing its innovative Alpha DaRT cancer therapy at multiple prestigious investor conferences in late 2024, with CFO Raphi Levy presenting updates and engaging in one-on-one investor meetings. The company’s participation includes the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference.
For further insights into DRTS stock, check out TipRanks’ Stock Analysis page.
